Robert D Carlson

6PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2026
Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

|Feb 23, 2026
DSG2-Directed CAR-T Cells Safely and Universally Eliminate Solid Tumors.

Adam Snook, Robert Carlson, Lindsay Weil

|Sep 24, 2024
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy.

Trevor R Baybutt, Ariana A Entezari, Adi Caspi

|Jun 23, 2022
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.

John C Flickinger, Ross E Staudt, Jagmohan Singh

|Feb 07, 2022
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy.

Ross E Staudt, Robert D Carlson, Adam E Snook

|Jun 27, 2020
Mobilizing Toxins for Cancer Treatment: Historical Perspectives and Current Strategies.

Jessica Kopenhaver, Robert D Carlson, Adam E Snook

Pageof 1

Frequent Collaborators

6 joint publications

Adam Snook

3 joint publications

Scott Waldman

3 joint publications

Ross E Staudt

2 joint publications

Joshua R Barton